﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>12</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2022</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period</ArticleTitle>
    <FirstPage>51</FirstPage>
    <LastPage>55</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2021.22167</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nadezhda V.</FirstName>
        <LastName>Maksimova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4276-0625</Identifier>
      </Author>
      <Author>
        <FirstName>Anna V.</FirstName>
        <LastName>Michenko</LastName>
      </Author>
      <Author>
        <FirstName>Olga A.</FirstName>
        <LastName>Krasilnikova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8069-9952</Identifier>
      </Author>
      <Author>
        <FirstName>Ilya D.</FirstName>
        <LastName>Klabukov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2888-7999</Identifier>
      </Author>
      <Author>
        <FirstName>Igor Yu.</FirstName>
        <LastName>Gadaev</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2782-4179</Identifier>
      </Author>
      <Author>
        <FirstName>Michael E.</FirstName>
        <LastName>Krasheninnikov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3574-4013</Identifier>
      </Author>
      <Author>
        <FirstName>Pavel A.</FirstName>
        <LastName>Belkov</LastName>
      </Author>
      <Author>
        <FirstName>Aleksey V.</FirstName>
        <LastName>Lyundup</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0102-5491</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2021.22167</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>05</Month>
        <Day>26</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>07</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Mesenchymal stromal cells (MSCs) administration is an effective option for the treatment of diabetic foot ulcers (DFUs). However, to date, studies assessing long-term outcomes and evaluating skin parameters after cell-based therapy are lacking. We presented the clinical outcomes of 3 patients, treated for DFUs with the bone marrow MSCs 3 years earlier. Methods: Ultrasound examination was used to compare collagen density and epidermal thickness in areas of healed ulcers in comparison with non-affected skin used as a control. Ultrasound and dermatoscopy were used to exclude neoplasm formation, to assess scar contracture and wound recurrence. Results: In all patients, no ulcer recurrence was detected, which was lower than the expected 60% rate of re-ulceration in diabetic patients in a 3-year period (OD [odds ratio] = 0.095, P = 0.12). No neoplasm formation, no contracture of hypertrophic scar, and adjacent tissue were registered. Collagen ultrasound density was decreased by 57% (P = 0.053) and epidermal thickness was increased by 72% (P = 0.01) in the area of healed ulcers in all patients.  Conclusion: MSCs therapy alone did not result in the complete restoration of the skin parameters within a 3-year period. MSCs may represent important adjuvant to the therapy, however, other novel approaches are required to achieve better results.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cell therapy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetic foot ulcer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesenchymal stem cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesenchymal stromal cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Regenerative medicine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Wound healing</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>